A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma

Anticancer Research

Volumn 29, Issue 6, 2009, Pages 2323-2329

  Brener, Sylvie ^a   González Moles, Miguel Angel ^b   Tostes, Denise ^a   Esteban, Francisco ^c   Gil Montoya, Jose Antonio ^b   Ruiz Ávila, Isabel ^d   Bravo, Manuel ^b   Muñoz, Miguel ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF GRANADA   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d Pathology Department   (Spain)

Author keywords

NK 1 receptor; Oral cancer; Proliferation; Substance P

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY KI 67; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE LEVEL; TUMOR CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL MEMBRANE; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PROGNOSIS; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 67650899068     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
2. Munger K: The role of human papillomaviruses in human cancers. Front Biosci 7: 641-649, 2002.
3. Castle PE, Hillier S, Rabe L, Hildesheim A, Herrero R, Bratti MC, Sherman ME, Burk RD, Rodriguez AC, Alfaro M, Hutchinson ML, Morales J and Schiffman M: An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 10: 1021-1027, 2001. (Pubitemid 32959148)
4. Syrjanen KJ: HPV infections and oesophageal cancer. J Clin Pathol 55: 721-728, 2002.
5. Pérez-Ayala M, Ruiz-Cabello F, Esteban F, Concha A, Redondo M, Oliva MR, Cabrera T and Garrido F: Presence of HPV16 sequences in laryngeal carcinomas. Int J Cancer 46: 8-11, 1990. (Pubitemid 20225779)
6. Naumann M and Crabtree J: Helicobacter pylori-induced epithelial cell signaling in gastric carcinogenesis. Trends Microbiol 12: 29-36, 2004.
7. Hilleman M: Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus. Vaccine 21: 4626-4649, 2003. (Pubitemid 37329857)
8. Rosin MP, Anwar WA and Warde AJ: Inflammation, chromosomal instability and cancer: the schistosomiasis model. Cancer Res 54: 1929S-1933S, 1994. (Pubitemid 24132148)
9. Manninga C, Vallyathanb V and Mossman B: Diseases caused by asbestos: mechanisms of injury and disease development. Int Immunopharmacol 2: 191-200, 2002. (Pubitemid 34075410)
10. Hökfelt T, Pernow B and Wahren J: Substance P: a pioneer amongst neuropeptides. J Intern Med 249: 27-40, 2001.
11. Quartara L and Maggi CA: The tachykinin NK-1R receptor. Part II: distribution and pathophysiological roles. Neuropeptides 32: 1-49, 1998.
12. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely D, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ and Rupniak NM: Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281: 1640-1645, 1998. (Pubitemid 28435572)
13. Harrison S and Geppetti P: Substance P. Int J Biochem Cell Biol 33: 555-576, 2001.
14. Bang R, Sass G, Kiemer AK, Vollmar AM, Neuhuber WL and Tiegs G: Neurokinin-1 receptor antagonists CP-96,345 and L-733,060 protect mice from cytokine-mediated liver injury. J Pharmacol Exp Ther 305: 31-39, 2003. (Pubitemid 36373833)
15. Koon HW and Pothoulakis C: Immunomodulatory properties of substance P: the gastrointestinal system as a model. Ann N Y Acad Sci 1088: 23-40, 2006. (Pubitemid 47092045)
16. Muñoz M, Pérez A, Coveñas R, Rosso M and Castro E: Antitumoral action of L-733,060 on neuroblastoma and glioma cell lines. Arch Ital Biol 142: 105-112, 2004a. (Pubitemid 38691234)
17. Muñoz M, Pérez A, Rosso M, Zamarriego C and Rosso R: Antitumoral action of NK1R receptor antagonist L-733,060 on human melanoma cell lines. Melanoma Res 14: 183-188, 2004b. (Pubitemid 38879579)
18. Muñoz M, Rosso M, Pérez A, Coveñas R, Rosso R, Zamarriego C and Piruat JI: The NK-1R receptor is involved in the antitumoral action of L-733,060 and in the mitogenic action of substance P on neuroblastoma and glioma cell lines. Neuropeptides 39: 427-432, 2005a. (Pubitemid 41073623)
19. Muñoz M, Rosso M, Pérez A, Coveñas R, Rosso R and Zamarriego C: Antitumoural action of the neurokinin-1-receptor antagonist L-733,060 and mitogenic action of substance P on human retinoblastoma cell lines. Invest Ophthalmol Vis Sci 46: 2567-2570, 2005b. (Pubitemid 43119507)
20. Muñoz M, Rosso M, Aguilar FJ, Gonzalez-Moles MA, Redondo M and Esteban F: NK-1 receptors antagonists induce apoptosis and counteract substance-P related mitogenesis in human laryngeal cancer cell line Hep-2. Invest New Drugs 26: 111-118, 2008.
21. Muñoz M, Rosso M, Coveñas R, Montero I, Gonzalez-Moles MA and Robles MJ: Neurokinin-1 receptors located in human retinoblastoma cell lines: antitumour action of its antagonist, L-732,138. Invest Ophthalmol Vis Sci 48: 2775-2781, 2007. (Pubitemid 351261233)
22. Johnson N, Franceschi S, Ferlay J, Ramadas K, Schmid S, MacDonald DG, Bugnot JE and Slootweg PJ: Squamous cell carcinoma. In: Tumours of the Oral Cavity and Oropharynx. Barnes L, Eveson JW, Reichart P and Sidransky D (eds.). World Health Orgaization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon 2005.
23. DeVane CL: Substance P: a new era, a new role. Pharmacotherapy 21: 1061-1069, 2001.
24. Manthy PW: Substance P and the inflammatory and immune response. Ann NY Acad Sci 632: 263-271, 1991.
25. Harrison S and Geppetti P: Substance P. Int J Biochem Cell Biol 33: 555-576, 2001.
26. Culman J and Unger T: Central tachykinins: mediators of defence reaction and stress reactions. Can J Physiol Pharmacol 73: 885-891, 1995.
27. De Felipe C, Herrero JF, O'Brien JA, Palmer JA, Doyle CA, Smith AJ, Laird JM, Belmonte C, Cervero F and Hunt SP: Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 392(6674): 394-397, 1998. (Pubitemid 28168736)
28. Esteban F, Muñoz M, Gonzalez-Moles MA and Rosso M: A role for substance P in cancer promotion and progression: a mechanism to counteract intracellular death signals following oncogen activation or DNA damage. Cancer Metastasis Rev 25: 137-145, 2006. (Pubitemid 43723988)
29. Koon HW, Zhao D, Na X, Moyer MP and Pothoulakis C: MetaUoproteinases and transforming growth factor-α mediate substance P-induced mitogen-activated protein kinase activation and proliferation in human Colonocytes. J Biol Chem 279: 45519-45527, 2004. (Pubitemid 39491538)
30. Weinstock JV, Blum A and Walden T: Eosinophils from granulomas in murine Schistosomiasis mansoni produce SP. J Immunology 141: 961-966, 1998.
31. Cook GA, Elliott D, Metwali A, Blum AM, Sandor M, Lynch R and Weinstock JV: Molecular evidence that granuloma T lymphocytes in murine Schistosomiasis mansoni express an authentic SP (NK1) receptor. Immunology 152: 1830-1835, 1994.
32. Gonzalez-Moles MA, Mosqueda-Taylor A, Esteban F, Gil-Montoya JA, Diaz-Franco MA and Delgado M: Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours. Oral Oncol 2008 (in press).
33. Gonzalez-Moles MA, Esteban F, Ruiz-Avila I, Gil-Montoya JA, Brener S, Bascones-Martinez A and Muñoz M: A role for substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus. Oral Dis 15: 162-169, 2009.
34. Boer PA and Gontijo JA: Nuclear localization of SP, CGRP, and NK1RR in a subpopulation of dorsal root ganglia subpopulation cells in rats. Cell Mol Neurobiol 26: 191-207, 2006.
35. Nowicki M, Ostalska-Nowicka D, Konwerska A and Miskowiak B: The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow. J Clin Pathol 59: 935-941, 2006. (Pubitemid 44422847)
36. Levy MJ, Classey JD, Maneesri S, Meeran K, Powell M and Goadsby PJ: The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours. Pituitary 7: 67-71, 2004. (Pubitemid 40372984)
37. Singh D, Joshi DD, Hameed M, Qian J, Gascón P, Maloof PB, Mosenthal A and Rameshwar P: Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: Implications for bone marrow metastasis. Proc Natl Acad Sci USA 97: 388-393, 2000. (Pubitemid 30055841)
38. Goso C, Potier E, Manzini S and Szallasi A: Comparison of tachykinin NK1 receptors in human IM9 and U373 MG cells, using antagonist (FK888, (+/-)-CP-96,345, and RP 67580) binding. Eur J Pharmacol 254: 221-227, 1994. (Pubitemid 24098557)
39. Ding HF and Fisher DE: Induction of apoptosis in cancer: new therapeutic opportunities. Ann Med 34: 451-469, 2002. (Pubitemid 36026777)
40. Keränen U, Järvinen H, Kärkkäinen P, Kiviluoto T, Kivilaakso E and Soinila S: Substance P - an underlying factor for puchitis? Prospective study of substance P and vasoactive intestinal polypeptide- immunoreactive innervations and mast cells. Dig Dis Sci 41: 1665-1671, 1996. (Pubitemid 26285759)
41. Hennig IM, Laissue JA, Horisberger U and Reubi JC: Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer 61: 786-792, 1995.
42. Seegers HC, Hood VC, Kidd BL, Cruwys SC and Walsh DA: Enhancement of angiogenesis by endogenous substance P release and neurokinin-1 receptors during neurogenic inflammation. J Pharmacol Exp Ther 306: 8-12, 2003. (Pubitemid 36734351)